Zelira is committed to evidence-based cannabinoid medicines and investing in clinical trials. We develop medicines designed to treat specific indications including chronic insomnia and behaviours associated with autism. Our insomnia trial was recently published in the prestigious Sleep journal. We're looking for partners for licensing and/or distribution into global markets including NZ. If this is of interest, please get in contact for an initial discussion.Greg BlakeVP – Global Head of Commercial and [email protected]
- Forums
- ASX - By Stock
- ZLD
- Interesting
Interesting
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZLD (ASX) to my watchlist
(20min delay)
|
|||||
Last
46.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.22M |
Open | High | Low | Value | Volume |
46.0¢ | 48.5¢ | 46.0¢ | $3.918K | 8.246K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12444 | 46.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
48.0¢ | 2285 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 12444 | 0.460 |
2 | 7533 | 0.450 |
1 | 6800 | 0.435 |
2 | 3222 | 0.400 |
1 | 1400 | 0.360 |
Price($) | Vol. | No. |
---|---|---|
0.480 | 2285 | 1 |
0.490 | 2072 | 2 |
0.500 | 429 | 3 |
0.510 | 79 | 1 |
0.520 | 350 | 2 |
Last trade - 14.43pm 05/06/2024 (20 minute delay) ? |
Featured News
ZLD (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non-Executive Director
Simon Kidston
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online